Influence of Napsin A expression and IASLC grade on the efficacy of pemetrexed in combination with platinum regimen for patients with advanced lung adenocarcinoma

XU Jun; CHEN Junping; CHENG Lanlan; WANG Jian; LV Donglai

doi:10.3969/j.issn.1009-0460.2022.07.002

Home>Articles>Influence of Napsin A expression and IASLC grade on the efficacy of pemetrexed in combination with platinum regimen for patients with advanced lung adenocarcinoma

DOI: 10.3969/j.issn.1009-0460.2022.07.002

Influence of Napsin A expression and IASLC grade on the efficacy of pemetrexed in combination with platinum regimen for patients with advanced lung adenocarcinoma

XU Jun

CHEN Junping

CHENG Lanlan

WANG Jian

LV Donglai

Machine-generated Keywords：

Publication Date：2022-07-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：7( 583-589 )

Chinese Clinical Oncology

ISTICPKU

ISSN：1009-0460

Year, Vol.(Issue)：2022,27(7)